SEC Form 4 · accession 0001015820-17-000046
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
QIAGEN NV
10% Owner
Period of report
Oct 26, 2017
Accepted (ET)
Nov 7, 2017 · 7:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $3.984 | Oct 26, 2017 | P | 753,012 | A | Oct 26, 2017 | Oct 26, 2020 | Common Stock | 753,012 | 753,012 | I |
Explanation of responses
- F1On October 26, 2017, the Reporting Person purchased a 3% Convertible Promissory Note in the principal amount of $3,000,000 initially convertible into 753,012 shares of common stock.